The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCGW.L Regulatory News (CGW)

  • There is currently no data for CGW

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Yearly Report

17 Apr 2015 15:50

RNS Number : 6202K
Chelverton Growth Trust PLC
17 April 2015
 



Investment objective

 

 

The Company's objective is to provide capital growth through investment in companies listed on the Official List and trade on the Alternative Investment Market ("AIM") with a market capitalisation at the time of investment of up to

£50 million, which are believed to be at a "point of change".The Company will also invest in unquoted investments where it is believed that there is a likelihood of the shares becoming listed or traded on AIM or the investee company being sold. Its investment objective is to increase net asset value per share at a higher rate than other quoted smaller company trusts and the MSCI Small Cap UK index.

 

Investment policy

 

 

The Company invests principally in securities of publicly quoted UK companies, though it will invest in unquoted securities. The concentrated UK portfolio comprises between 20 to 35 securities. The performance of the Company's investments is compared to the MSCI Small Cap UK index.

 

The Company will also invest in unquoted investments where it is believed that there is a likelihood of the shares becoming listed or traded on AIM or the investee company being sold.

 

It is the Company's policy not to invest in any listed investment companies or listed investment trusts.

 

 

It is intended from time to time, when deemed appropriate, that the Company will borrow for investment purposes. The Company, currently has borrowing facilities in place with Jarvis Investment Management Limited.

 

Investment strategy

 

Investments are selected for the portfolio only after extensive research which the Investment Manager believes to be key. The whole process through which equity must pass in order to be included in the portfolio is very rigorous. Only a security where the Investment Manager believes that the price will be significantly higher in the future will pass the selection process. The Company's Investment Manager believes the key to successful stock selection is to identify the long-term value of a company's shares and to have the patience to hold the shares until that value is appreciated by other investors. Identifying long-term value involves detailed analysis of a company's earning prospects over a five year time horizon.

 

The Company's Investment Manager is Chelverton Asset Management Limited, a specialist investment manager focusing exclusively on achieving returns for investors based on UK investment analysis of the highest quality. The founder and employee owners of Chelverton include experienced investment professionals with strong investment performance records who believe rigorous fundamental research allied to patience is the basis of long-term investment success.

 

Chairman's Report

 

The Company's net asset value per share has softened slightly in the last six months falling from 51.38p to 51.03p, a decrease of 0.7%. This represents an underperformance against the MSCI Small Cap UK index.

 

During the period, the world's financial markets have endured a period of unpredictability. The global economy continued to grow steadily, however financial markets entered a period of re-adjustment as they came to the realisation that historically low inflation and interest rates are likely to persist for longer than they had previously assumed. We have also witnessed a substantial strengthening of the US Dollar and a sudden collapse in commodity prices. This has resulted in a marked change in sentiment towards certain companies and caused considerable variations in the performance of individual stocks. Such divergence is highlighted by the performance of the two indices by which we internally judge ourselves. During the period, the commodity heavy AIM All-share fell by 8.2% whilst the MSCI Small Cap UK index increased by 8.1%.

Looking forward, we are in a period where the approaching UK General Election will dominate domestic news. Although this election is being contested against an economic background that is fundamentally positive, with falling unemployment, modestly rising living standards, solid economic growth and increasing house prices; predicting the outcome or exact make up of the next government is almost impossible. Whatever the outcome of the election, we expect in the short term, that the market will generally be driven by positive results from companies and a steady stream of good news about the state of the real economy.

 

On the European front, the election of a "left wing" government in Greece has brought a return to the spotlight of the unresolved problems faced by the Eurozone; this continues to be a drag on sentiment and will remain so in the foreseeable future.

 

The Fund Manager's impression gained by meeting the management from many of the companies in our portfolio is that in general, they are continuing to make steady progress and there are emerging signs that the much hoped for rebalancing of the UK economy is actually starting to happen. Access to finance continues to be an issue for many small companies. Although on a day-to-day basis this is not hampering growth too much, they remain conscious that if the economy was to change direction suddenly, or if a step change in the business was required, they lack the availability adequate funding. In the longer term, this could become a real issue and prevent them from maximising their full potential.

 

In the past six months further selected reductions in the quoted holdings were made, mainly to fund the tender offer made to shareholders in March 2015. Sales were made in IDOX, Tristel and A B Dynamics and post the period end, in Alliance Pharma and Lombard Risk Management.

 

The unquoted proportion of the fund continued to make good progress. The valuation of our holding in Chelverton Asset Management (CAM) has been increased to reflect the strong performance of the business. This enabled CAM to redeem a large proportion of the loan notes which were issued to help fund the Management Buyout of the company. Chelverton Growth Trust redeemed its entire holding of Loan Notes whilst retaining the equity part of its investment.

 

A further increase in value was recognised in Parmenion Capital Partners as it continued on its strong growth path, adding further funds under administration. An additional investment of £75,000 was made into Transflex which helped assist the financing of its new southern depot. The addition of the new depot should provide a base for further growth over the next few years. La Salle Education raised further funds to finance its development.

 

These factors resulted in the unquoted proportion of the fund to rise to 48.4% of the portfolio.

 

Plutus Powergen, a recent addition to our quoted portfolio, performed well following some very positive news.

 

The Company completed its sixth tender offer in March 2015 with the purchase of 944,624 shares at 47.2p each. The tender price was calculated as being equal to 92.5 per cent of the net asset value per share on 27 February 2015.

 

Valid applications were received from eligible shareholders in respect of a total of 3,419,061 ordinary shares (representing approximately 36.2 per cent of the Company's issued ordinary share capital at the record date). These shares were subsequently cancelled leaving a reduced share capital of 8,501,650 shares in issue. In the absence of any unexpected events it is the Board's intention to repeat the process following the Company's year-end. In the Board's opinion, this strategy makes complete sense, especially if shares in the Company continue to trade, as currently, at a 17.6% discount to the Net Asset Value.

 

Looking ahead to the second half of the year, once the outcome of the election is resolved, we can look forward to continuing growth in the UK economy and can consequently expect further positive prospects for our investee companies.

 

 

Kevin Allen

Chairman

 

16 April 2015

 

 

Principal risks and uncertainties

 

 

The Board considers that the principal risks and uncertainties facing the Company for the remaining six months of the financial year remain the same as those disclosed in the interim management report on page 2 and also on pages 11 and 12 of the Report of the Directors in the Annual Report for the year ended 31 August 2014. These risks include market risk, discount volatility, regulatory risks, financial risk and liquidity risks.

 

 

Responsibility statement

 

 

The Directors are responsible for preparing the unaudited half yearly financial report in accordance with applicable law and regulations. The Directors confirm that to the best of their knowledge:

 

 

- the condensed set of financial statements for the six months to 28 February2015, has been prepared in accordance with the Statement on Half Yearly Financial Reports issued by the UK Accounting Standards Board.

 

- the interim management report together with the notes to the Half Yearly Report include a fair review of the

information required by;

 

rule 4.2.7Rof the Disclosure and Transparency Rules, being an indication of important events that have occurred during the first six months of the financial year and their impact on the condensed set of financial statements; and a description of the principal risks and uncertainties for the remaining six months of the year; and

 

rule 4.2.8R of the Disclosure and Transparency Rules, being related party transactions that have taken place in the first six months of the current financial year and that have materially affected the financial position or performance of the Company during that period; and any changes in the related party transactions described in the last Annual Report that could do so (see note 5).

 

Going concern

 

The Company's assets consist mainly of equity shares in companies which, in most circumstances are realisable within a short timescale. The Directors believe that the Company has adequate resources to continue in operational existence for the foreseeable future. Accordingly, they continue to adopt the going concern basis in preparing the accounts.

 

This Half Yearly Financial Report was approved by the Board of Directors on 16 April 2015. 

 

Kevin Allen

Chairman

 

 

 

Portfolio review

as at 28 February2015

 

The Company's portfolio is set out below.

 

 

Investment

Sector

Valuation

£'000

% of

Total

AIM traded

AB Dynamics

Industrial Engineering

Design and manufacture of advanced testing and measurement products to the automotive industry

80

1.67

Alliance Pharma

Pharmaceuticals & Biotechnology

Acquisition of the manufacturing, sales and distribution rights to pharmaceutical products

219

4.56

Belgravium Technologies

Technology Hardware & Equipment

Software systems for warehousing and distribution

285

5.93

CEPS

Support Services

Production and supply of components for the footwear industry; personal protection equipment; production of printed lycra fabric; and services to the direct mail industry

340

7.08

IDOX

Software & Computer Services

Software company specialising in the development of products for document information management

202

4.22

Lombard Risk Management

Software & Computer Services

Lombard Risk is one of the world's leading providers of collateral management, liquidity analysis and regulatory compliance software to financial organisations

285

5.93

LPA Group

Electronic & Electrical Equipment

Design, manufacture and marketing of industrial electrical accessories

129

2.69

MTI Wireless Edge

Technology Hardware & Equipment

Developer and manufacturer of sophisticated antennas and antenna systems

66

1.38

Northbridge Industrial Services

Industrial Engineering

Consolidation vehicle for specialist industrial hire services

143

2.97

Petards International Group

Support Services

Development, provision and maintenance of advance security systems and related services

108

2.25

Plutus Powergen

Financial Services

Providers of management infrastructure and expertise to operate power plants and provide flexible electricity generation

243

5.05

Tristel

Health Care Equipment & Services

Healthcare business specialising in infection control in hospitals

154

3.20

Universe Group

Support Services

Provision of credit fraud prevention system, loyalty system and retail systems

48

0.99

 

 

 

Nasdaq

 

One Horizon Group

Support Services

 

Provider of mobile satellite communications equipment and airtime

175

3.65

Unquoted

Airways Engineering

Support Services

Ordinary B Shares

-

-

Loan Stock

-

-

Commercial aviation maintenance

Anaxsys Technology

Healthcare Equipment & Services

A medical device company for patient monitoring and screening

52

1.08

Chelverton Asset Management Holdings

Support Services

Investment management, including providing services to Chelverton Growth Trust Plc

82

 1.70

Closed Loop recycling

Support Services

Ordinary B Shares

0

0.00

Loan Stock

168

3.50

Operation of a plastic (PET and HDPE) recycling plant

La Salle Education Limited

Support Services

A UK based company dedicated to improving mathematics education.

100

 

Main Dental Partners

Support Services

Ordinary B Shares

175

3.64

Loan Stock

0

0.00

Operator of dental surgeries

Parmenion Capital Partners

Support Services

Provides fund-based discretionary fund management services to Independent Financial Advisors

1,153

24.01

Security Research Group

Support Services

Leading provider of Local Authority residential property searches; provision of packaging solutions and technical surveillance countermeasure components

42

0.87

Transflex Vehicle Rental

Support Services

Light commercial vehicle rental

555

11.55

Portfolio Valuation

4,804

100

 

 

 

Portfolio of investments

28 February 2015

31 August 2014

 

Investment

Valuation

% holding

Valuation

% holding

£ '000

£ '000

Parmenion Capital Partners

1,153

24.0

1,105

22.0

Transflex Vehicle Rental

555

11.6

480

9.5

CEPS

340

7.1

300

6.0

Belgravium Technologies

285

5.9

315

6.3

Lombard Risk Management

285

5.9

255

5.1

Plutus Powergen

243

5.0

125

2.5

Alliance Pharma

219

4.6

195

3.9

IDOX

202

4.2

325

6.5

One Horizon Group

175

3.6

191

3.8

Main Dental

175

3.6

175

3.5

Closed Loop Recycling Limited (Loan Stock)

168

3.5

252

5.0

Tristel

154

3.2

187

3.7

Northbridge Industrial Services

143

3.0

177

3.5

LPA Group

129

2.7

193

3.8

Petards Group

108

2.2

113

2.2

La Salle Education Limited

100

2.1

100

2.0

Chelverton Asset Management Holdings

82

1.7

167

3.3

AB Dynamics

80

1.7

156

3.1

MTI Wireless

66

1.4

75

1.5

Anaxsys Technology

52

1.1

52

1.0

Universe Group

48

1.0

34

0.7

Security Research Group

42

0.9

55

1.1

Total

4,804

100

5,027

100

 

Percentage of portfolio by sector

 

Sector

Percentage

Software and Computer Services

10.14

Support Services

57.68

Technology Hardware & Equipment

7.31

Industrial Engineering

4.64

Pharmaceuticals & Biotechnology

4.56

Electronic & electrical equipment

2.69

Health Care Equipment & services

4.29

Mobile Telecommunications

3.64

Financial Services

5.05

Percentage of Portfolio by Index

AIM

47.92

Unquoted

48.44

Nasdaq

3.64

 

 

 

Income statement(unaudited)

for the six months to 28 February2015

 

 

Six months to

28 February 2015

Year to

31 August 2014

Six months to

28 February 2014

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

Gains on investments at fair value

19

19

-

752

752

-

562

562

Income

35

-

35

57

-

57

22

-

22

Investment management fee*

(6)

(19)

(25)

(13)

(38)

(51)

(6)

(19)

(25)

Other expenses*

(59)

(4)

(63)

(119)

(8)

(127)

(60)

(2)

(62)

Net return on ordinary activities before taxation

(30)

(4)

(34)

(75)

706

631

(44)

541

497

Taxation on ordinary activities

-

-

-

-

-

-

-

-

-

Net return on ordinary activities

(30)

(4)

(34)

(75)

706

631

(44)

541

497

Revenue

pence

Capital

pence

Total pence

Revenue

pence

Capital

pence

Total pence

Revenue

pence

Capital

pence

Total pence

Return per Ordinary share#

(0.32)

(0.04)

(0.36)

(0.76)

7.15

6.39

(0.42)

5.2

4.78

 

Notes

*  75%of the management fee and finance costs have been charged to capital reserve.

#  The return per Ordinary share is based on 9,446,274 (31 August 2014: 9,871,859; 28 February 2014: 10,403,842) shares, being the weighted average number of shares in issue during the period.

 

The total column of this statement is the profit and loss account of the Company.

 

All revenue and capital items in the above statement derive from continuing operations.

 

A separate statement of total recognised gains and losses has not been prepared as all such gains and losses are included in the income statement.

 

 

 

Reconciliation of movements in shareholders' funds (unaudited)

for the six months to 28 February 2015

 

 

Share

Capital

£'000

Share premium account £'000

 

Capital reserve £'000

Capital redemption reserve £'000

 

Revenue reserve £'000

 

 

Total

£'000

Six months to 28 February 2015

1 September 2014

96

2,674

556

993

1,435

4,854

Cost of shares purchased for cancellation under tender offer

-

-

-

-

-

-

Net return after taxation for the period

-

-

(4)

-

(30)

(34)

28 February 2015

96

2,674

552

93

1,405

4,820

Year to 31 August 2014

1 September 2013

106

2,674

(150)

83

1,996

4,709

Cost of shares purchased for cancellation under tender offer

(10)

-

-

10

(486)

(486)

Net return after taxation for the period

-

-

706

-

(75)

631

31 August 2014

96

2,674

556

93

1,435

4,854

Six months to 28 February 2014

1 September 2013

106

2,674

(150)

83

1,996

4,709

Cost of shares purchased for cancellation under tender offer

(10)

-

-

10

(486)

(486)

Net return after taxation for the period

-

-

541

-

(44)

497

28 February 2014

96

2,674

391

93

1,466

4,720

Balance sheet (unaudited)

as at 28 February 2015

 

 

As at

28 February 2015 £'000

As at

31 August 2014 £'000

As at

28 February 2014

£'000

 

 

Fixed assets

 

Investments at fair value

4,804

5,027

4,856

Current assets

 

Debtors

2

8

4

Cash at bank

454

40

277

456

48

281

Creditors - amounts falling due within one year

 

Creditors

40

21

17

Short-term loan

400

200

400

440

221

417

Net current (liabilities)/assets

 

16

173

136

Net assets

4,820

4,854

4,720

Share capital and reserves

Share capital

96

96

96

Share premium account

2,674

2,674

2,674

Capital reserve

552

556

391

Capital redemption reserve

93

93

93

Revenue reserve

1,405

1,435

1,466

Equity shareholders' funds

4,820

4,854

4,720

Net asset value per Ordinary share (note 1)

51.03p

51.38p

49.98p

 

 

 

 

 

 

 

 

Statement of cash flows (unaudited)

for the six months to 28 February 2015

 

 

Six months to

28 February 2015

Year to

31 August 2014

Six months to

28 February 2014

Operating activities

Investment income received

35

57

22

Investment management fees paid

(25)

(51)

(25)

Secretarial fees paid

(18)

(36)

(18)

Other cash payments

(20)

(94)

(47)

Net cash outflow from operating activities (note 3)

(28)

(124)

(68)

Investing activities

Purchase of investments

(75)

(560)

(219)

Sales of investments

317

993

633

Net cash inflow from investing activities

242

433

414

Financing

Cost of shares purchased for cancellation

 under tender offer

-

(486)

(486)

New Loan

200

400

-

Capital repayment of loan

-

(200)

-

Net cash inflow/(outflow) from financing activities

200

(286)

(486)

Increase/(decrease) in cash

414

23

(140)

 

 

 

Notes to the half yearly report

 

 

The unaudited interim financial information does not constitute statutory accounts as defined in Section 434 of the Companies Act 2006. The statutory accounts for the year to 31 August 2014, which contained an unqualified auditors' report, have been lodged with the Registrar of Companies and did not contain a statement required under Section 498

(2) or (3) of the Companies Act 2006. The financial information for the period ended 28 February 2015 and 28 February 2014 have not been audited or reviewed by the Company's Auditor pursuant to the Auditing Practices Board guidance on such reviews.

 

This information has been prepared on the basis of accounting policies set out in the statutory accounts of the Company for the year to 31 August 2014.

 

 

Net asset value

The basic net asset value per Ordinary share is based on net assets of £4,820,000 (31 August 2014: £4,854,000; 28 February2014: £4,720,000) and on 9,446,274 Ordinary shares(31 August 2014:9,446,274; 28 February 2013: 10,495,860) being the number of Ordinary shares in issue at the period end.

 

 

Taxation

The tax charge for the six months to 28 February 2015 is nil (year to 31 August 2014: nil; six months to 28 February 2014: nil).

The Company has an effective tax rate of 0% for the year ending 31 August 2014. The estimated effective tax rate is 0% as investment gains are exempt from tax owing to the Company's status as an Investment Trust and there is expected to be an excess of management expenses over taxable income.

 

 

Reconciliation of net return before finance costs and taxation to net cash outflow from operating activities

 

Six months to

28 February 2015

£'000

Year to

31 August 2014

£'000

Six months to

28 February 2014

£'000

Net return before finance costs and taxation

(34)

631

497

Net capital return before finance costs

4

(706)

(541)

Expenses charged to capital

(23)

(46)

(21)

(Decrease)/increase in creditors and accruals

19

(3)

(7)

Decrease/(increase) in prepayments and accrued income

6

-

4

Net cash outflow from operating activities

(28)

(124)

(68)

 

 

 

Called up share capital

The Board of directors made the decision to delay the Tender Offer until after the completion of the NAV for February 2015. On 20 March 2015 944,624 shares were repurchased for cancellation leaving 8,501,650 ordinary shares of 1p in issue.

 

 

 

Related party transactions

Chelverton Asset Management Limited is the Investment Manager. Mr Horner, a Director of the Company, is also a Director of Chelverton Asset Management Limited and Chelverton Asset Management Holdings Limited. He is also a director of CEPS PLC, in which the Company has an investment.

 

At 28 February 2015 there was £4,200 (31 August 2014: £4,200; 28 February2014: £4,000) payable to the Investment Manager.

 

The Company and its directors have the following commercial interest in the Investment Manager's holding company; Chelverton Asset Management Holdings Limited.

 

Loan Stock

Ordinary Shares

£

David Horner

1,301,119

56,250

Chelverton Growth Trust plc

-

2,000

Ian Martin

-

2,000

Kevin Allen

40,000

1,000

The total Ordinary share interest held by the Company and the Independent Directors represents five percent of the voting rights.

 

David Horner, including his family interest, is the majority share holder with 56.25 percent of the voting rights in Chelverton Asset Management Holdings Limited.

 

Status of Company

It is the intention of the Directors to conduct the affairs of the Company so that they satisfy the conditions for approval as an investment trust company as set out in Sections 1158/1159 of the Corporation Tax Act 2010.

 

Alternative Investment Fund Management Directive (AIFMD)

 

The Board of Directors are registered as Alternative Investment Fund Manager (AIFM) with the FCA and confirm that all regulatory returns have been completed and filed.

Directors and advisers

 

 

Directors

Kevin Allen (Chairman) David Horner

Ian Martin

 

 

Investment Manager

Chelverton Asset Management Limited 12b George Street

Bath BA1 2EH Tel: 01225 483 030

 

Secretary and Registered Office John Girdlestone

Chartered Accountant

Waterside Court

Falmouth Road

Penryn

Cornwall

TR10 8AW

Tel: 01326 378 288

john@girdlestone.org.uk

 

Registrar and Transfer Office

Share Registrars Limited Suite E

First Floor

9 Lion and Lamb Yard Farnham

Surrey GU9 7LL Tel: 01252 821 390

www.shareregistrars.uk.com

Auditors Hazlewoods LLP Windsor House Bayshill Road

Cheltenham GL50 3AT

 

Custodian and Banker Jarvis Investment Management Limited

78 Mount Ephraim

Royal Tunbridge Wells

TN4 8BS

Tel: 01892 510 515

 

 

 

 

 

 

 

 

 

 

Information about the Company can be obtained at the Investment Manager's website at www.chelvertonam.com.

 

An investment company as defined under Section 833 of the Companies Act 2006.

REGISTERED IN ENGLAND No. 2989519

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR GGUQCCUPAGCM
Date   Source Headline
27th Nov 20233:42 pmRNSResult of Meeting
27th Nov 202310:30 amRNSSuspension - Chelverton Growth Trust plc
14th Nov 202312:36 pmRNSNet Asset Value(s)
1st Nov 20237:00 amRNSPublication of Circular and Notice of GM
9th Oct 20232:27 pmRNSNet Asset Value(s)
11th Sep 20234:41 pmRNSNet Asset Value(s)
25th Aug 20237:00 amRNSNet Asset Value(s)
4th Aug 202311:25 amRNSHolding(s) in Company
31st Jul 20239:59 amRNSHolding(s) in Company
31st Jul 20239:55 amRNSHolding(s) in Company
17th Jul 202311:02 amRNSNet Asset Value(s)
13th Jun 202310:28 amRNSNet Asset Value(s)
10th May 202311:09 amRNSNet Asset Value(s)
24th Apr 20237:00 amRNSHalf-year Report
6th Apr 20237:00 amRNSNet Asset Value(s)
20th Mar 20235:46 pmRNSDirector/PDMR Shareholding
3rd Mar 20235:03 pmRNSNet Asset Value(s)
6th Feb 20237:00 amRNSNet Asset Value(s)
16th Jan 20232:56 pmRNSHolding(s) in Company
16th Jan 202310:58 amRNSNet Asset Value(s)
15th Dec 20222:06 pmRNSResult of AGM
7th Dec 20221:11 pmRNSNet Asset Value(s)
10th Nov 20227:00 amRNSNet Asset Value(s)
9th Nov 20227:00 amRNSFinal Results
11th Oct 202210:55 amRNSNet Asset Value(s)
23rd Sep 20227:00 amRNSNet Asset Value(s)
5th Aug 202211:56 amRNSNet Asset Value(s)
6th Jul 202212:53 pmRNSNet Asset Value(s)
13th Jun 202212:40 pmRNSNet Asset Value(s)
16th May 20223:52 pmRNSNet Asset Value(s)
14th Apr 20223:12 pmRNSHalf-year Report
6th Apr 20227:00 amRNSNet Asset Value(s)
21st Mar 20227:00 amRNSNet Asset Value(s)
10th Feb 202211:43 amRNSNet Asset Value(s)
12th Jan 20225:52 pmRNSNet Asset Value(s)
11th Jan 20221:03 pmRNSResult of AGM
20th Dec 20213:11 pmRNSNet Asset Value(s)
16th Nov 20211:51 pmRNSFinal Results
9th Nov 20212:48 pmRNSNet Asset Value(s)
6th Oct 202110:03 amRNSNet Asset Value(s)
30th Sep 20215:32 pmRNSHolding(s) in Company
27th Sep 20212:38 pmRNSNet Asset Value(s)
12th Aug 202112:27 pmRNSNet Asset Value(s)
11th Aug 20212:52 pmRNSHolding(s) in Company
11th Aug 20212:48 pmRNSHolding(s) in Company
6th Jul 20214:42 pmRNSNet Asset Value(s)
5th Jul 20211:56 pmRNSHolding(s) in Company
10th Jun 20213:28 pmRNSHolding(s) in Company
9th Jun 202112:01 pmRNSDirector/PDMR Shareholding
9th Jun 202111:59 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.